Clinical Trials Directory

Trials / Completed

CompletedNCT04025606

Paravertebral Block Versus Thoracic Epidural Analgesia

Paravertebral Block Versus Thoracic Epidural Analgesia in Patients Undergoing Video Assisted Lung Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
St. Olavs Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Thoracic epidural analgesia (TEA) is the basic method of analgesia in patients undergoing pulmonary lobectomy. TEA is considered to be a safe and thoroughly investigated method of pain relief that rarely causes serious complications. However, blocking the nerves as they emerge from the spinal column (paravertebral block, PVB) may represent an alternative method with some potential benefits. In this study, TEA and PVB will be compared for patients undergoing pulmonary lobectomy by video assisted thoracoscopic surgery. The aim of the study is to test the hypothesis, that PVB is a time-saving procedure compared with TEA on the day of surgery and that PVB is as efficient in postoperative pain reduction as TEA.

Conditions

Interventions

TypeNameDescription
DRUGThoracic epiduralStandard thoracic epidural (needle inserted into the space between the covering of spinal cord and the cord itself) preoperatively. Standard thoracic epidural analgesia mixture (2 mg/ ml bupivacaine, 2 µg/ ml fentanyl and 2 µg/ ml adrenalin) with an infusion of 6-10 ml/hour until day 2 postoperatively. Thereafter reduction by 30 % every four hours.
DRUGParavertebral blockParavertebral block containing 5 ml bupivacaine 5 mg/ ml (optionally 10 ml bupivacaine 2,5 mg/ ml). In addition per-oral painkillers (oxycodone and paracetamol) from the day of surgery.

Timeline

Start date
2019-06-24
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-07-19
Last updated
2024-01-03

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04025606. Inclusion in this directory is not an endorsement.